Literature DB >> 1668104

Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes.

A G Stewart1, T Harris.   

Abstract

The bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (fMLP), induces the generation of platelet-activating factor (PAF), the mobilization of arachidonic acid and generation of superoxide anion (O2-) in rabbit polymorphonuclear leukocytes (PMNs). The PAF receptor antagonists, WEB 2086 (10-100 microM) and CV 6209 (1-10 microM), reduced the mobilization of arachidonic acid and the O2- generation in response to fMLP but not that in response to A23187. Pretreatment of PMNs with the phospholipase A2 inhibitor, chloroquine, or the serine protease inhibitor, tosyl-phenylalanine chloromethyl ketone, reduced the fMLP-stimulated generation of PAF and also reduced the generation of O2-. The respiratory burst induced by a submaximal concentration of phorbol myristate acetate was not affected by these compounds. These data are consistent with the suggestion that endogenous PAF may contribute to the signal transduction cascade initiated by fMLP.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668104     DOI: 10.1007/bf02536499

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  28 in total

1.  Increased superoxide anion production by immunologically activated and chemically elicited macrophages.

Authors:  R B Johnston; C A Godzik; Z A Cohn
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

Review 2.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

3.  Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes.

Authors:  L Parente; R J Flower
Journal:  Life Sci       Date:  1985-04-01       Impact factor: 5.037

4.  Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.

Authors:  J H Sisson; S M Prescott; T M McIntyre; G A Zimmerman
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

5.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.

Authors:  A G Stewart; P N Dubbin; T Harris; G J Dusting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.

Authors:  Z Terashita; Y Imura; M Takatani; S Tsushima; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

7.  Production and release of platelet-activating factor (PAF); dissociation from degranulation and superoxide production in the human neutrophil.

Authors:  S J Betz; P M Henson
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

8.  Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.

Authors:  J Casals-Stenzel; G Muacevic; K H Weber
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

9.  G-protein beta gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2.

Authors:  D Kim; D L Lewis; L Graziadei; E J Neer; D Bar-Sagi; D E Clapham
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

10.  Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.

Authors:  G Camussi; F Bussolino; G Salvidio; C Baglioni
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  5 in total

1.  Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent.

Authors:  I Daniels; M A Lindsay; C I Keany; R P Burden; J Fletcher; A P Haynes
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

2.  Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.

Authors:  A G Stewart; T Harris
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

3.  Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.

Authors:  P P McDonald; S R McColl; P Braquet; P Borgeat
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

4.  Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls.

Authors:  P K Tithof; E Schiamberg; M Peters-Golden; P E Ganey
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

5.  Production of oxygen free radicals by Ehrlich ascites tumour cells: effect of lipids.

Authors:  G K Marathe; C J D'Souza
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.